HF mice that had received C18 treatment and presented with similar-to-sham S1P plasma levels revealed a significantly lower number of splenic S1P1+ CD3+ T-cells (Figure 4c) and other S1P1+ immune cells (Table 1). This evidence concerns the gene S1PR1 and hydrops fetalis.